CAN DIET HELP WITH HIV, CANCER AND INFERTILITY? Lancet Review Examines the Importance of Selenium to Human HealthJuly 13, 2000GPs and health professionals will learn from a report to be published in the Lancet on 15 July that the effect of including selenium in a daily diet, is more wide ranging in its health aspects than was ever suspected. In the first such review of selenium in a prestigious medical journal, the author of the report, Dr Margaret Rayman of the University of Surrey, refers to over 80 research projects from around the world. These show that the vital role of selenium in human health ranges from slowing down the progression of HIV to Aids, to improving fertility in men and women; from enhancing people’s mood to reducing the risk of cancer, the latter being an area of Rayman’s own research. Selenium, a trace mineral, which occurs naturally in the soil and can be found in brazil nuts, offal, grain, fish and meat, has been found to have other benefits which include positive effects on viral infections, asthma, rheumatoid arthritis, and thyroid function. Selenium therefore may provide a low cost answer to preventing a number of diseases but the low or diminishing selenium levels in some countries is giving cause for concern. On being asked about why she had decided to write a review, Dr Rayman replied: “There are three main reasons. First, to provide GPs and healthcare professionals with reliable information which could be used in treating patients and setting up healthcare programmes. Second, to raise concern that the levels of selenium are low in the UK and parts of Europe. Third, to call for further research to clarify the optimal nutritional level with respect to selenium.” Dr Rayman explained that if, for example, there was further research to examine whether selenium as a nutrient could be helpful in slowing the progression of HIV to Aids, then it might provide a low cost solution in African countries particularly affected by HIV. The research so far had been carried out in the United States by Mariana Baum and colleagues of the University of Miami who found that HIV positive individuals have a twenty times greater chance of dying from Aids than those with adequate selenium levels. The Cancer Research Campaign is currently funding a £160,000 pilot study, which started in October 1999 led by Dr Rayman, and involves 500 people in the UK to see whether selenium can provide protection against cancer. This comes after an American study which showed encouraging health benefits for people who increased their daily intake of selenium. Dr Rayman said: “I am currently trying to raise £3.5m in funding to carry out a main UK study involving 10,000 people, when the pilot research finishes at the end of next year. It is essential to get sponsorship as scientific research is the only way to get positive proof of the health benefits of selenium. If a positive effect of selenium on cancer risk were to be established, the Government might then decide to act by adding selenium to the food supply. However, research is also needed to discover the optimal nutritional level with respect to selenium, because if people consume too much then it can become toxic”. Besides Britain, Sweden and Denmark are also taking part in the trial because of low dietary selenium. The US who are also participating in the study, have moderate selenium levels. The difference in countries’ selenium levels depends on the amount of selenium present in the soil and which fertilisers are used. Finland has artificially added selenium to its fertilisers since 1984 to raise levels because of the reputed health benefit. In contrast, selenium levels in the UK have declined significantly over the last few decades – probably because we are no longer importing selenium-rich wheat from North America for use in our bread. Media Enquiries: Jacqui Spiers, University Press Office, tel. 01483 879314 or Dr Margaret Rayman who is available by phone as follows: Wednesday 12 July: Until 3.00pm tel. 01483 876447. After 8.00pm tel. 07712 183401 13 & 14 July: Free except between 11.00am and 2.00pm on 13 July. Tel. 07712 183401 From evening of 14 July, onwards: 01483 562882. Surrey, University of |
|||||||||||||||||||||
| Related HIV Current Events and HIV News Articles Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Many pregnant women avoid HIV screening in Africa 'Prevention is the best cure' is a common expression, but what happens if preventative measures are not used? A large proportion of pregnant Ugandan women are going out of their way not to be HIV tested, increasing the risk of mother-to-child transmission. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Hoping for a fluorescent basket case Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem. Scientists explain binding action of 2 key HIV antibodies; could lead to new vaccine design A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||